Literature DB >> 8695793

Anti-erythropoietin receptor monoclonal antibody: epitope mapping, quantification of the soluble receptor, and detection of the solubilized transmembrane receptor and the receptor-expressing cells.

E Morishita1, H Narita, M Nishida, N Kawashima, K Yamagishi, S Masuda, M Nagao, H Hatta, R Sasaki.   

Abstract

A hybridoma cell line producing the monoclonal antibody against erythropoietin receptor (EpoR) was established using the soluble ectodomain of mouse erythropoietin receptor (sEpoR) as an antigen. The monoclonal antibody termed 1G3 bound to the denatured sEpoR. Epitope mapping with peptide library revealed that 1G3 recognized the amino terminal region including the hexapeptide (positions 6 to 11; LeuProAspProLysPhe). The amino acid sequence in this hexapeptide was identical in mice, rats, and humans, and therefore 1G3 bound to EpoR from all of these sources. Using 1G3, we evaluated sEpoR by a sandwich enzyme-linked immunoassay, and EpoR in the solubilized membrane preparation was detected by Western blotting. The cells expressing EpoR were identified with immunochemical staining. We confirmed the presence of EpoR in a neuronal cell line and PC12 cells, and EpoR was expressed in primary cultured hippocampal neurons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8695793

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  The AKT/mTOR pathway mediates neuronal protective effects of erythropoietin in sepsis.

Authors:  Guo-Bin Wang; Yun-Lan Ni; Xin-Ping Zhou; Wei-Fang Zhang
Journal:  Mol Cell Biochem       Date:  2013-09-22       Impact factor: 3.396

2.  In vivo evidence that erythropoietin protects neurons from ischemic damage.

Authors:  M Sakanaka; T C Wen; S Matsuda; S Masuda; E Morishita; M Nagao; R Sasaki
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

3.  Erythropoietin enhancer stimulates production of a recombinant protein by Chinese hamster ovary (CHO) cells under hypoxic condition.

Authors:  S K Moon; S Takeuchi; T Kambe; T Tsuchiya; S Masuda; M Nagao; R Sasaki
Journal:  Cytotechnology       Date:  1997-11       Impact factor: 2.058

4.  Effect of hypoxia duration on the oxygen-dependent production of a recombinant protein, β-galactosidase, by an animal cell line, F6D2, with a hypoxia-inducible enhancer.

Authors:  Y Shirai; M Inagaki; M Yamaguchi; T Kambe; M Nagao; S Masuda; R Sasaki
Journal:  Cytotechnology       Date:  1997-11       Impact factor: 2.058

5.  JAK2/STAT5/Bcl-xL signalling is essential for erythropoietin-mediated protection against apoptosis induced in PC12 cells by the amyloid β-peptide Aβ25-35.

Authors:  Rong Ma; Jing Hu; Chengfang Huang; Min Wang; Jizhou Xiang; Gang Li
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

6.  Erythropoietin expands a stromal cell population that can mediate renoprotection.

Authors:  Baoyuan Bi; Jiankan Guo; Arnaud Marlier; Shin Ru Lin; Lloyd G Cantley
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-23

7.  In vitro neuroprotective action of recombinant rat erythropoietin produced by astrocyte cell lines and comparative studies with erythropoietin produced by Chinese hamster ovary cells.

Authors:  S Masuda; E Kada; M Nagao; R Sasaki
Journal:  Cytotechnology       Date:  1999-09       Impact factor: 2.058

8.  In vitro neuroprotective action of recombinant rat erythropoietin produced by astrocyte cell lines and comparative studies with erythropoietin produced by Chinese hamster ovary cells.

Authors:  S Masuda; E Kada; M Nagao; R Sasaki
Journal:  Cytotechnology       Date:  1999-05       Impact factor: 2.058

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.